Epstein Secrets

e other EFTA00135850 half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

al overtones." The New Ynrk Times (12/7, Herndon, 18.61M) looks at GOP strategy in the contests, writing that Republicans are focusing primarily on Raphael Warnock, the African American minister challenging Sen. Kelly Loeffler (R-GA), and largely ignoring Jon Ossoff, the Democratic challenger to Sen. David Per

and hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people n

nate-debate-wanock- loeffler.html> (12/7, Herndon, 18.6IM) looks at GOP strategy in the contests, writing that Republicans are focusing primarily on Raphael Warnock, the African American minister challenging Sen. Kelly Loeffler (R-GA), and largely ignoring Jon Ossoff, the Democratic challenger to Sen. David Perd

nd hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

al overtones." The New York Times (12/7, Herndon, 18.61M) looks at GOP strategy in the contests, writing that Republicans are focusing primarily on Raphael Warnock, the African American minister challenging Sen. Kelly Loeffler (R-GA), and largely ignoring Jon Ossoff, the Democratic challenger to Sen. David Per